Transition to phacoemulsification at the farabi eye hospital, Iran

Hashemi, Hassan; Mohammadi, Seyed Farzad; Mazouri, Arash; Majdi-N, Mercede; Jabbarvand, Mahmoud; Z-Mehrjardi, Hadi

doi:10.4103/0974-9233.80709

Cited by 4 publications

(4 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[ 7 8 ] This improvement has been partly attributed to transition to phacoemulsification in Iran. [ 25 ] This period coincides with our systematic review span. Having significant cataract-related VI despite acceptable or high CSR means that cataract surgical coverage (CSC) is insufficient and points to disparities in access in one hand and induced demand on the other hand.…”

Section: Discussionsupporting

confidence: 79%

Prevalence and major causes of visual impairment in Iranian adults: A systematic review

Mohammadi

Saeedi-Anari

Ashrafi

et al. 2017

Middle East Afr J Ophthalmol

Self Cite

View full text Add to dashboard Cite

PURPOSE:The purpose of this study is to provide a pooled estimate of moderate-to-severe visual impairment (MSVI) and blindness in Iran for people 50 years and over and to identify the major causes through systematic review.MATERIALS AND METHODS:International (PubMed, ISI Web of Science, and Scopus) and national databases (Scientific Information Database, Barakat Knowledge Network System, Iran Databank of Ophthalmology Research, and Magiran) databases were searched. Following relevance assessment and critical appraisal, eight studies were included. A funnel plot was drawn to explore the stability for estimation. Single-variable meta-regression analysis was applied for heterogeneity assessment, and a random effect model was used (but no significant source for the observed heterogeneity was found).RESULTS:Age-standardized pooled estimate of MSVI was 4.24% (95% confidence interval [CI]: 2.92–5.56); 3.98% (95% CI: 2.37–5.59) for men, and 4.08% (95% CI: 2.95–5.21) for women. Blindness (visual acuity <3/60) prevalence was 1.31% (95% CI: 1.23–1.39); 0.96% (95% CI: 0.89–1.03) for men, and 1.13% (95% CI: 1.06–1.20) for women. Causes of visual impairment (VI) were cataract (40.23%), amblyopia (12.03%), corneal opacity (9.63%), age-related macular degeneration (9.31%), diabetic retinopathy (4.94%), and glaucoma (3.67%).CONCLUSION:VI prevalence in the 50 years and older population in Iran seems significantly better than the corresponding global estimates. A rough 60% rate of treatable VI was estimated, mostly attributable to unoperated cataract.

show abstract

Section: Discussionsupporting

confidence: 79%

Prevalence and major causes of visual impairment in Iranian adults: A systematic review

Mohammadi

Saeedi-Anari

Ashrafi

et al. 2017

Middle East Afr J Ophthalmol

Self Cite

View full text Add to dashboard Cite

show abstract

“…[ 12 ] This difference may be attributed to our hospital-based setting and the fact that most procedures (>90%) employed phacoemulsification, analogous to developed countries, which is known to be associated with better outcomes. There has been a well-established transition into phacoemulsification in Iran[ 23 ] but SICS and ECCE are still the preferred methods of cataract surgery in many developing countries,[ 24 ] owing to cost and a technological gap. Despite the university affiliation of our hospital, most eyes (66.4%) were treated in the non-educational service by experienced phacoemulsification surgeons, and operations in the educational setting were supervised by the faculty.…”

Section: Discussionmentioning

confidence: 99%

Outcomes of cataract surgery at a referral center

Mohammadi¹,

Hashemi²,

Mazouri³

et al. 2015

J Ophthalmic Vis Res

Self Cite

View full text Add to dashboard Cite

Purpose:To report the outcomes of cataract surgery at a large referral eye hospital and to identify factors associated with less than excellent visual outcomes.Methods:Hospital records of patients, who had undergone age-related cataract extraction (1,285 procedures) within a two-year period were sampled randomly for 353 patients (405 eyes) and baseline characteristics were recorded. Up to three causes of visual loss (contributory reasons) were considered and the principal cause of “less than excellent outcome,” i.e., best spectacle corrected visual acuity (BSCVA) <20/25 was defined as the primary reason.Results:Mean age of the participants was 68.6 years, and 50.7% of enrolled subjects were female. Phacoemulsification had been performed in 92.1% of cases. Out of 405 eyes, 54%, 78%, and 97% achieved BSCVA of ≥20/25, ≥20/40, and ≥20/200, respectively. Poor visual outcomes were significantly associated with older age (OR: 4.55 for age >70 years), female gender (OR: 4.64), ocular comorbidities (OR: 7.68), surgically challenging eyes (OR: 7.33), long and short eyes (versus eyes with normal axial length, OR: 3.24), and being operated on by a novice surgeon (OR: 2.41). The leading contributory reasons for unfavorable outcome, in descending order were maculopathy (17%), posterior capsule opacification (PCO, 11.8%), corneal opacity (5.7%), and degenerative myopia (5.4%).Conclusion:Maculopathy, PCO, corneal opacity, degenerative myopia and ARMD may contribute to unfavorable outcomes in cataract surgery.

show abstract

“…The availability of phacoemulsification for wider age groups and those with systemic comorbidities play an important role in the decreased DALY for cataract in Iran. 12 In fact, theoretically cataract loses its chronic disease classification because surgical care is provided as soon as it is needed. Two opposing processes, namely, epidemiologic transition and access to the sight-restorative surgery play a role in the change in DALY attributed to cataract in Iran.…”

Section: Discussionmentioning

confidence: 99%

“…This may explain the observation that changes in the cataract burden are comparatively lower than other blinding conditions. 12 …”

Section: Discussionmentioning

confidence: 99%

National Burden of Eye Diseases in Iran, 1990–2010; findings from the global burden of diseases study 2010

Hatef

Mohammadi

Alinia

et al. 2016

Middle East Afr J Ophthalmol

View full text Add to dashboard Cite

Purpose:The disability-adjusted life-years (DALYs) lost due to eye diseases and trends in DALYs in Iran has not been previously reported. The object of this study is to report the burden of eye diseases in Iran and to compare changes from 1990 to 2010 based on age and gender.Methods:Data from the Global Burden of Disease Study 2010 (GBD 2010) are used to report DALYs for cataract, refraction/accommodation (functional) disorders, macular degeneration, and glaucoma.Results:Cataract, refraction/accommodation (functional) disorders, macular degeneration, and glaucoma were the 84th, 87th, 138th, and 151st causes of DALY in 1990 and the 89th, 72nd, 99th, and 137th in 2010, respectively. Cataract accounted for 0.085% of national DALY in 1990 and 0.09% in 2010, refraction/accommodation (functional) disorders accounted for 0.42% in 1990 and 0.47% in 2010, macular degeneration accounted for 0.017% in 1990 and 0.071% in 2010 and glaucoma accounted for 0.0099% in 1990 and 0.025% in 2010. There was a steady increase in DALY with age for each eye disease for both genders and dichotomized for males and females from 1990 to 2010.Conclusions:Epidemiologic transition is reflected in major ophthalmic and blinding diseases in the GBD data for Iran. The burden of macular degeneration is rising, followed by glaucoma. The burden of presbyopia affected individuals past their middle age. The burden of cataract manifested as a slower increase that could be attributable to better access to treatment.

show abstract

Transition to phacoemulsification at the farabi eye hospital, Iran

Cited by 4 publications

References 22 publications

Prevalence and major causes of visual impairment in Iranian adults: A systematic review

Prevalence and major causes of visual impairment in Iranian adults: A systematic review

Outcomes of cataract surgery at a referral center

National Burden of Eye Diseases in Iran, 1990–2010; findings from the global burden of diseases study 2010

Contact Info

Product

Resources

About